by Madaline Spencer | Oct 9, 2025
Jannine Williams, Compound Development Team Leader at Johnson & Johnson, discusses key takeaways from studies on hemolytic disease of the fetus and newborn (HDFN) presented at ISUOG World Congress 2025. HDFN is a rare condition characterized by the...
by Madaline Spencer | Oct 8, 2025
Araz Marachelian, MD, Pediatric Oncologist at Children’s Hospital Los Angeles, discusses the New Approaches to Neuroblastoma (NANT) Consortium and its work in neuroblastoma. Neuroblastoma is a rare cancer that largely afflicts infants or children. It...
by Madaline Spencer | Oct 1, 2025
Makayla Alger, patient advocate with TUBB4B, and her mother Joann Alger, discuss their experience with the condition and the need for awareness. The TUBB4B gene is a gene believed to be involved in microtubule cytoskeleton organization and the mitotic...
by Madaline Spencer | Sep 30, 2025
Navin Pinto, MD, Professor of Pediatrics at the University of Colorado Anschutz Medical Campus and Colorado Children’s Hospital, discusses the Children’s Oncology Group and their work in neuroblastoma. Neuroblastoma is a rare cancer that largely afflicts...
by Madaline Spencer | Sep 29, 2025
Jamas LaFreniere, Founder of Sophie’s Hope Foundation and CURE GSD1b, and Blair Stone-Schneider, Executive Director of Sophie’s Hope Foundation, discuss their patient advocacy organization and starting a natural history study for glycogen storage disease type 1b...
